ADHF
8
3
3
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
66.7%
-19.8% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF)
Evaluation of the Diagnostic Value of the TPD System in Determining ADHF Causing Acute Dyspnea
Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
Role of the Mespere Venus 1000 in Predicting Heart Failure Hospital Readmissions
PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients
3-dimensional Sensor Technology to Quantify Leg-edema
Troponin I Release After High Diuretic Doses